Abstract
Introduction
In the treatment of talar osteochondral defects (OCDs), repair of the subchondral bone is an important aim of the procedure. 160 The presence of subchondral bone is essential for survival of chondrocytes. 16 The affected subchondral bone is thought to cause the pain. 434 Restoration of the subchondral bone may improve the weight-bearing capacity of the ankle and prevent further cyst formation. 434 Urist pioneered the use of demineralized bone matrix (DBM) for bone defects. 405, 419 Since his work, there has been increasing experience with DBM in both animals 123, 140, 272, 405 and humans. 145, 283 The sequence of events after implantation of DBM mirrors that of endochondral ossification. 405 Bone morphogenetic proteins 171
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(BMP-2, -4, and -7) seem to be responsible for the formation of bone and possibly cartilage that are induced by DBM. 318, 406 Th e BMPs present in DBM attract mesenchymal stem cells through chemotaxis and act as morphogens that may direct the diff erentiation of these cells into an osteochondrogenic lineage. Diff erent fl uids can be used for rehydration of the DBM before application, including normal saline, bone marrow aspirate, antibiotics solution, whole blood, or platelet concentrate.
Platelet-rich plasma (PRP) is a promising biomaterial that contains concentrated growth factors, including transforming growth factor-β (TGF-β) and platelet-derived growth factor (PDGF). 14, 195 TGF-β in PRP may stimulate chemotaxis and mitogenesis of osteoblast and chondroblast precursors and inhibit osteoclast formation and bone resorption. 225, 275 PDGF may promote mitogenesis, angiogenesis, and chondrocyte proliferation. 10, 225, 275 Although, in theory, PRP may enhance the biologic activity of DBM, the combination of DBM and PRP has had contradictory results. 213, 275, 324 Th e purpose of the present study was to evaluate the eff ectiveness of DBM with or without PRP in the treatment of ankle OCDs in goats. We hypothesized that (1) treatment with DBM would repair more bone than control OCDs, and that (2) PRP would further enhance the regenerative capacity of DBM.
Materials and methods

Animals and experimental design
Th e study was approved by the Animal Care and Use Committee of the University of Amsterdam. A caprine model was used, specifically designed for ankle OCDs. 417 Sixteen adult female Dutch milk goats (Capra Hircus Sana) were included with an approximate age of 4 years. All goats were healthy, according to physical examination and blood tests performed by a veterinarian. Th e goats were weighed on a digital scale before surgery and at fi nal followup. Surgery was performed in a sterile manner on both ankles, with the goat under general anesthesia with endotracheal intubation. A single intramuscular dose with prophylactic antibiotics (Pen & Strep, Fendigo sa/nv, Brussels, Belgium) was injected preoperatively. Th e ankle joint was exposed through a posteromedial approach. Normal articular surfaces were confi rmed by visual inspection. Standard OCDs of 6 mm in diameter and depth were created with specially developed instruments.
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According to a predefi ned randomization scheme, one defect of each goat was treated with DBM hydrated either with normal saline (0.9% NaCl solution) ("DBM treatment"; n = 8) or with PRP ("DBM+PRP treatment"; n = 8), and the other served as a control ("DBM control" or "DBM+PRP control"). In each case, the material was inserted press-fi t up to the level of the adjacent cartilage surface. Th e joint capsule and skin were closed in a standard fashion.
During recovery, the animals were kept outdoors in a large natural environment, without activity restrictions, and with food ad libitum. Eating habits, ambulatory activities, and health status were monitored daily.
Since previous studies showed no substantial change in repair of knee OCDs aft er 24 weeks, 72,138 the goats were euthanized 24 weeks aft er surgery by injecting a lethal intravenous dose of pentobarbital. All analyses were performed by observers blinded to the treatment provided.
Demineralized bone matrix
Commercially available cortical DBM (Bonus TM DBM, Biomet BV, the Netherlands) was used. Th is DBM was obtained from human donors from qualified tissue banks that were registered with the FDA and accredited by the American Association of Tissue Banks. It was granulated, demineralized with organic solvents, freezedried (i.e., lyophilized) and processed aseptically. This process resulted in calcium levels of less than 0.1%. 318 It was combined with a collagenderived carrier (gelatin) from the same donor, packaged in a rehydration syringe, and sterilized by gamma irradiation.
Platelet-rich plasma
Autologous PRP was used for rehydration of the DBM. After induction of anesthesia and before surgery, 27 ml venous goat blood was aspirated into a 30-ml syringe that contained 3 ml of anticoagulant citrate dextrose A. PRP was isolated by centrifugation at 3200 rpm for 15 min using the gravitational platelet system II (GPS II, Biomet BV, the Netherlands). This preparation system produces 3 ml of PRP with a reported eightfold increase in platelet concentration and a fourfold to sevenfold increase in growth factor concentration compared with whole blood. 120, 173, 454 The concentration of platelets in the PRP of each subject in the present study was measured using an automated hematology analyzer (XE-5000, Sysmex, Japan) after 5 min of resuspension on a rocker, as recommended by Woodell-May et al. 454 The median platelet concentration of the PRP was 1511 × 10 9 /l (range, 82 -2090 × 10 9 /l).
Macroscopy
After the goats were euthanized, the tali were excised and digital high-resolution photographs were taken of the talar articular surfaces. Two independent observers macroscopically graded the photographs with use of the validated International Cartilage Repair Society (ICRS) cartilage repair assessment. 62, 420 This score ranges from 0 to 12 points and is subdivided into degree of defect repair, integration to border zone, and macroscopic appearance (4 points each), with a score of 12 indicating a completely normal appearance. The scores of the two observers were averaged, and outliers with a difference of more than 1 point were scored by consensus. 
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Micro-computed tomography
Th e anterior part of the talus, at safe distance from the OCD, was sawn off with a water-cooled band saw to reduce the size of the specimen, allowing it to be placed in the micro-computed tomography (mCT) scanner, and to optimize penetration of fi xative into the specimen. Aft er 1 week in fi xative (4% phosphate-buff ered formaldehyde), the specimens were submerged in 70% ethanol and temporarily subjected to a vacuum. In the 70% ethanol solution, they were placed in a mCT scanner (μCT 40, Scanco Medical AG, Bassersdorf, Switzerland) and scanned with a resolution of 18 μm. To minimize the noise in the reconstructions, an integration time of 1000 ms was used.
Micro-CT reconstructions were segmented with a threshold level of 467 mg HA/ cm 3 . Two 3-dimensional cylindrical volumes of interest were defi ned: one representing the complete OCD (6 mm in diameter and depth), and one representing the central OCD (3 mm in diameter and 5 mm in depth) ( Figure 1 ). Using morphometric soft ware (Scanco Medical AG, Bassersdorf, Switzerland), the following parameters were analyzed: bone volume fraction (bone volume [BV]/tissue volume [TV]), tissue mineral density (TMD) of BV and of TV, and trabecular number, thickness, and separation. Th e bone volume fraction was the primary outcome of the study.
Histology
Aft er fi xation, the specimens were dehydrated using ascending grades of alcohol and embedded in methyl-methacrylate. Aft er cold polymerization, the undecalcifi ed specimens were cut into 5-μm sections with a Jung-K microtome (R. Jung, Heidelberg, Germany). Th irty central sections were obtained of each specimen to overcome sampling error. Every third section was stained with Goldner's trichrome method or toluidine blue for light microscopy, or left unstained for fl uorescence microscopy. Two observers simultaneously assessed the stained sections and identifi ed the type of healing.
Histomorphometry
A representative Goldner-stained mid-section of each talus was analyzed using a Leica DMRA microscope that was connected to Leica Qwin computer soft ware (Leica Microsystems Imaging Solutions, Cambridge, UK) with a custom-made routine for quantitative measurements of bone parameters. Two observers simultaneously made the choice for the representative section, based on technical quality and overall appearance. Th ree areas of interest were defi ned: (1) the center of the OCD, (2) sides and bottom of the defect (close to the lateral, medial, and deep borders), and (3) the surface (close to the articular surface of the defect). 417 For each area of interest, one (surface), two (center) or three (sides and bottom) representative measurement fi elds of 3.07 × 10 5 µm 2 were digitized at a magnifi cation of ×200. Mineralized bone surface area (bone%) and osteoid surface area (osteoid%) were assessed. Th e numbers of osteocytes, osteoblasts, and osteoclasts were counted at a magnifi cation of ×400 and expressed per area of mineralized bone tissue. Th ese histomorphometric measurements have been shown excellent intraobserver and interobserver reliability.
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Fluorescence microscopy
Fluorochrome labels were administered at week 1 (Oxytetracyclin yellow, 32 mg/kg intramuscularly) and weeks 6, 12, 18, and 23 (Calcein green, 20 mg/kg subcutaneously). Fluorescence microscopy was used with fl uorescence fi lters and unstained sections to analyze the speed of bone regeneration (mineral apposition rate [MAR] ). Six measurement fields (magnification, ×400) were digitized, similar to the areas of interest of histomorphometry. The distance between two consecutive fluorescent bone labels was measured at approximately 10 locations within a measurement field by an independent observer blinded to treatment allocation. The MAR (mm/day) was calculated as the average distance divided by the number of days between two injections.
Statistical analysis
The sample size was calculated before the start of the study and was based on the primary outcome BV/TV. Prior data from a pilot study indicated that the standard deviation of BV/TV in the central 3 mm of the OCDs treated with DBM was 0.086. 417 With an intended difference in the mean BV/TV of matched pairs of 0.10, a sample size of eight ankle pairs was able to reject the null hypothesis that the response difference was zero with probability (power) 0.80. The Type I error probability associated with this test of this null hypothesis was 0.05. Because two pairs of treatment were investigated, the total sample size was 16 goats.
Statistical analyses were performed with use of SPSS software (version 18.0; Chicago, Illinois). Variables with normal distribution are reported as mean and 95% confidence intervals (CIs). Data with skewed distribution are reported as median and range. The Wilcoxon signed-rank test was used to calculate p-values of matched pairs (DBM vs. control and DBM+PRP vs. control). The Mann-Whitney U test was used to compare the treatment effect of DBM (i.e., difference of DBM and internal control) with the treatment effect of DBM+PRP (i.e., difference of DBM+PRP and internal control). MARs of different administration periods were compared using the Wilcoxon signed-rank test.
The results were considered statistically significant if the p-value was less than 0.05 for the primary outcome (i.e., BV/TV). To correct for multiple testing, Holm's method was used for the secondary outcome parameters (macroscopy, histology, histomorphometry, and fl uorescence microscopy).
9,186 Because four secondary outcome measures were used, adjusted p-values with signifi cance levels of 0.01 (i.e., 0.05/4) and higher were appropriate.
Results
General results
Th e surgical procedures and functional recovery were uneventful in 15 goats. Aft er 24 h, no signs of limping or abnormal motion were observed. In one goat, there was a technical failure of the instruments, resulting in an OCD drilled completely through the talus. In consultation with the Animal Care and Use Committee, this animal was terminated and replaced by another, which had no complications. Th e mean body weight was 73.5 kg (95% CI, 67.1 -79.8 kg) before surgery and 69.3 kg (95% CI, 63.7 -75.0 kg) at 24 weeks follow-up.
Macroscopy
All OCDs were macroscopically covered with fi brocartilaginous tissue. Th e mean ICRS cartilage repair assessment was 8.0 (95% CI, 7.3 -8.7) for DBM treatment, 8.4 (95% CI, 7.4 -9.5) for DBM control, 6.9 (95% CI, 5.3 -8.6) for DBM+PRP treatment, and 7.4 (95% CI, 6.0 -8.9) for DBM+PRP control (diff erences not statistically signifi cant) (Figure 2) . Th e surrounding talar cartilage and opposite joint surfaces appeared unaff ected.
Micro-CT
Th ere were no signifi cant diff erences between groups on the primary outcome measure BV/ TV or any of the other µCT parameters in either volume of interest ( Figure 3 and Table 1 ). In the DBM+PRP treatment group, there were no statistically signifi cant diff erences between goats with high concentrations of PRP and those with low concentrations. For example, BV/TV in the complete OCDs of the four goats with the highest PRP concentrations was 0.49 (95% CI, 0.39 The values are presented as the mean, with the 95% confidence interval in parentheses. There were no statistically significant differences between the groups. BV = bone volume, Tb.N = trabecular number, Tb.Sp = trabecular separation, Tb.Th = trabecular thickness, TMD = tissue mineral density, and TV = tissue volume. 
Histology
Four types of healing patterns were recognized (Figure 4) . Type 1 was almost completely healed (>75% repair). In type 2, the subchondral bone was (almost) restored but a cystic lesion underneath the restored bone remained. Type 3 was characterized by regeneration from the margins and bottoms of the defects but a superfi cial defect remained (25% -75% repair). In type 4, no or only minimal healing was observed (<25% repair); the original defects were fi lled with fatty and connective tissue, and the surface was covered with a thin layer of cells. Th ere was high variation in healing patterns between animals ( Figure 5 ), while the left and right tali within a single animal showed more consistency. Th ere were remnants of DBM in two cases: one DBM treatment and one DBM+PRP treatment. Additionally, macrophages were observed in fi ve defects: one DBM treatment, one DBM control, and three DBM+PRP control. Osteoclasts were not found.
Histomorphometry
Th ere were no statistically signifi cant diff erences in histomorphometry between the groups for any of the parameters analyzed in any of the areas of interest (Table 2) .
Fluorescence microscopy
Th ere were no statistically signifi cant diff erences between the groups (Table 3) . Some data were missing due to either no bone or no detectable label in the measurement fi eld, especially in the fourth administration period (week 18 -23) . Th e MAR of the second administration period (week 6 -12) of each group was signifi cantly higher than that of the fi rst administration period (week 1 -6). Th e MAR did not change signifi cantly in subsequent periods.
Discussion
Th is study aimed to evaluate the eff ectiveness of DBM and PRP in the treatment of ankle OCDs in goats. A previously established goat model was utilized, enabling evaluation of treatment of a standard OCD of the talus in a large animal with qualitative and quantitative analyses. 417 Th e control OCDs in this study can be regarded as bone marrow stimulation of the defect without additional fi lling.
In contrast to our hypotheses, DBM did not result in improved repair compared to the control defects, nor did PRP enhance the regenerative capacity of DBM. Th ere were no statistically signifi cant diff erences between the groups on the primary outcome BV/TV, as measured by µCT, or the secondary outcomes, as measured by macroscopy, histology, histomorphometry, and fl uorescence microscopy. However, some generalization uncertainty remains because of the dispersion of the outcome data, as demonstrated by the width of the 95% CIs (see Figure 3 and Tables 1 and 3 ). Th ere were no observations of abnormal motion or limping aft er 24 h. Although a signifi cantly higher MAR was shown aft er the fi rst 6 weeks, this fi nding was similar in each treatment group (see Table 3 ).
Gao et al. investigated the eff ect of allogeneic rabbit demineralized cortical and trabecular bone matrix for the treatment of 3-mm OCDs in 10 young rabbit medial femoral condyles.
140 At 6 and 12 weeks postoperatively, the defects were repaired up to 95% of their depth but there was a clear diff erence between cortical and trabecular DBM. In most of the specimens Figure 4 . Goldner-stained sections showing four types of healing. Type 1 (A) was almost completely healed. In type 2 (B) , the subchondral bone was (almost) restored but a cystic lesion underneath the restored bone remained. Type 3 (C) was characterized by regeneration from the margins and bottoms of the defects but a superficial defect remained. In type 4 (D), no or only minimal healing was observed. The original defects are indicated with black lines. Subtle differences in size of the defects may be due to slice preparation. The values are presented as the mean, with the 95% confidence interval in parentheses.
The MAR of the second administration period (week 6 -12) of each group was significantly higher than that of the first administration period (week 1 -6). The MAR did not change significantly in subsequent periods. MAR = mineral apposition rate and NA = not applicable. Th ey concluded that the synovial environment seemed to prevent bone formation otherwise induced by DBM. Th e present study investigated cortical DBM for talar OCDs and found no benefi cial eff ect. Th e diff erences in outcome between our study and the former studies might be due to the fact that we studied larger and older animals with larger OCDs. Additionally, an important diff erence between the studies is the joint investigated; the knee and ankle joints diff er in congruency, cartilage thickness, and loading characteristics. 85, 234, 399 Th ese joints might thus not be reliably compared in osteochondral defect healing models.
In general, the eff ectiveness of DBM depends on numerous variables, including the age of the donor, 347 the tissue bank and the lot, 172, 173, 450 prolonged heat treatment, 196 the size or shape of the graft particles, 155 the nature of the carrier material, the extent of residual bone mineral content, 459 and the method of sterilization. 171 However, most of these variables are not applicable to the commercially available DBM used in the current study. Th is type of DBM has shown consistent composition and proven eff ectiveness in previous studies using a heterotopic bone formation model and an in vitro model. 173, 317, 318 Possibly, the natural circumstances of the joint (i.e., high loading forces and possible intrusion of fl uid into the OCD) might preclude the eff ectiveness of the DBM in the present study. Remnants of the DBM were found in two specimens, suggesting not all the material had remodeled. Furthermore, DBM was used as a xenograft ; that is, human DBM was implanted in caprine OCDs. Th is might theoretically infl uence the eff ectiveness of DBM. However, the use of human DBM in animals did not seem to aff ect positive results in other studies. 173, 324 Hence, this aspect is probably not a good explanation for the lack of eff ectiveness. Th e immune response of the animals was not clearly related to the implantation of DBM; macrophages were observed in one DBM specimen and in four control specimens.
Th e addition of PRP to DBM has led to equivocal results in the literature. Butcher et al. found a signifi cant increase in DNA content and mineralization level by adding PRP to DBM in vitro. 67 Likewise, a viable osteochondral construct has been created with DBM and PRP ex vivo. 249 In contrast, Ranly et al. found a neutral or even inhibitory eff ect of PRP to the ectopic formation of bone induced by DBM in a nude mouse model. 324 Th is negative eff ect of PRP to DBM may have been caused by the activation with thrombin.
173 Han et al. demonstrated that PRP can increase the osteoinductivity of DBM, but only when it has not been activated by thrombin. 173 Even though in the present study the PRP was not activated with thrombin either, a benefi cial eff ect of PRP could not be demonstrated.
Strengths of this study include the use of an established model with a large animal; a power analysis to identify the minimal number of animals; an internal control in each goat; and numerous qualitative and quantitative analyses aft er relatively long follow-up.
Th e study also has limitations. Th ere was a single follow-up assessment of 24 weeks. This way, the number of goats required for the study could be limited to 16. Instead of using additional animals for shorter follow-up assessments, fluorochrome labels were injected at various moments during the follow-up period. This allowed analysis of the speed of repair during the recovery period and made the inclusion of additional animals unnecessary. Another limitation was the variable concentration of platelets in the PRP. The mean concentration was approximately four times that of unprepared caprine whole blood, but the dispersion was high. This variation was also observed in previous studies, 120, 275 and might be due to either the preparation or the analysis of PRP. Although both systems -GPS II for preparation and XE-5000 for analysis -have been developed for human blood, others have successfully used them in animals; e.g., a GPS II system for bovine blood (increasing the platelet concentration fourfold), 454 and an XE-2100 analyzer for rat PRP. 208 We therefore believe the systems can be used in other species. We also believe the observed variation in platelet concentration does not affect the conclusions, as there was no statistically significant difference (p = 1.0) in outcome between specimens with high concentrations and those with low concentrations of PRP. Besides, the ideal concentration of PRP remains unknown. 136, 195 Further studies are indicated to determine the optimal concentration of PRP as well as the ideal preparation of DBM before they can be uniformly investigated in (pre)clinical studies.
Conclusion
DBM with or without PRP was not beneficial in the treatment of OCDs of the talus in goats.
